Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.
Press releases published on October 22, 2025
I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025
Updated Phase 1 givastomig monotherapy data show an impressive 18% ORR in metastatic gastric cancer patients who had received at least two prior lines of therapy. Responses were observed over a dose range from 5 mg/kg Q2W up to 18 mg/kg Q3W No differences …
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data for …
Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets
– FMC-376 demonstrated robust anti-tumor activity across preclinical models and led to deeper inhibition of KRAS downstream pathways compared to sotorasib – – FMC-220 potently and selectively restored p53 tumor suppressor function and delivered tumor …
Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering
EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market Dynamix™: Hemophilia (US) 2025 and the accompanying Launch …
American Botanical Council Launches Tongkat Ali Video on HerbTV
Austin, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The nonprofit American Botanical Council (ABC) announces the premiere of the third video in its Adopt-an-Herb (AaH) Video Program: “Tongkat Ali: Maintaining Healthy Testosterone in Men and Women.” This …
Back to Life with Resuscitec’s CARL® Groundbreaking ECPR System – Nominated for the Prix Galien USA 2025 Award
FREIBURG, Germany, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Resuscitec GmbH is introducing a revolutionary medical technology that redefines the boundaries of emergency care. The company’s CARL® ECPR system - developed and engineered as a highly efficient …
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT …
La planta de productos farmacéuticos estériles de Curia es nombrada “Fabricante del Año” en Massachusetts
ALBANY, Nueva York, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), una organización líder en investigación, desarrollo y fabricación por contrato (CDMO), anunció hoy que su planta de productos farmacéuticos estériles en Burlington, MA ha …
Curias Anlage für sterile Arzneimittel als Hersteller des Jahres in Massachusetts ausgezeichnet
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), ein führendes Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, gab heute bekannt, dass seine Anlage für sterile Arzneimittel in Burlington, Massachusetts, vom …
L'usine de médicaments stériles Curia nommée fabricant de l'année dans le Massachusetts
ALBANY, N.Y., 22 oct. 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), une organisation leader dans la recherche, le développement et la fabrication sous contrat, a annoncé aujourd'hui que son usine de produits pharmaceutiques stériles de Burlington, …
מפעל מוצרי התרופות הסטרילי של Curia זכה בתואר יצרן השנה במסצ'וסטס
אולבני, ניו יורק, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (קוריה), ארגון מוביל למחקר, פיתוח וייצור לפי חוזים, הודיע היום כי מפעל מוצרי התרופות הסטריליות שלו בברלינגטון, מסצ'וסטס זכה בתואר "יצרן השנה" על ידי שדולת הייצור המחוקקת של מסצ'וסטס. …
Fasilitas Produk Obat Steril Curia Dinobatkan sebagai Produsen Terbaik Tahun Ini di Massachusetts
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), perusahaan penelitian, pengembangan, dan manufaktur terkemuka berbasis kontrak hari ini mengumumkan bahwa fasilitas produksi obat sterilnya di Burlington, Massachusetts, telah …
Instalação de Medicamentos Estéreis da Curia Nomeada Fabricante do Ano de Massachusetts
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- A Curia Global, Inc. (Curia), uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje que sua instalação de medicamentos estéreis em Burlington, MA, foi nomeada "Fabricante …
Curia (큐리아) 멸균 의약품 생산시설, 매사추세츠주 ‘올해의 제조업체(Manufacturer of the Year)’ 선정
뉴욕주 올버니, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc.(큐리아)는 오늘 매사추세츠주 벌링턴에 위치한 자사의 멸균 의약품 생산 시설이 매사추세츠 주 의회 제조업 코커스(Massachusetts Legislative Manufacturing Caucus) 로부터 ‘올해의 제조업체 (Manufacturer of the Year)’로 선정되었다고 발표했다. 이 상은 10월 21일 질레트 스타디움( …
Fasiliti Produk Ubat Steril Curia Dinobatkan sebagai Pengilang Terbaik Massachusetts Tahun Ini
ALBANY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), sebuah organisasi terkemuka dalam penyelidikan kontrak, pembangunan dan pembuatan, hari ini mengumumkan bahawa fasiliti produk ubat sterilnya di Burlington, Massachusetts telah …
โรงงานผลิตภัณฑ์ยาปลอดเชื้อ Curia ได้รับการเสนอชื่อให้เป็นผู้ผลิตแห่งปีของรัฐแมสซาชูเซตส์
ออลบานี รัฐนิวยอร์ก, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia) ซึ่งเป็นองค์กรชั้นนำด้านการวิจัย พัฒนา และการผลิตตามสัญญา ได้ประกาศในวันนี้ว่าโรงงานผลิตภัณฑ์ยาปลอดเชื้อในเบอร์ลิงตัน รัฐแมสซาชูเซตส์ ได้รับการเสนอชื่อให้เป็น "ผู้ผลิตแห่งปี" …
Are Americans Aware of Kratom? New Poll Says No Concerns Growing About Potential Risks of “Gas Station Heroin”
Washington, D.C., Oct. 22, 2025 (GLOBE NEWSWIRE) -- In recent months, news stories have covered the harms of kratom, the FDA has taken steps toward banning certain forms of it, some states are considering outlawing it, and the FDA commissioner sent a …